Literature DB >> 21810574

Creating a palliative educational session for hematopoietic stem cell transplantation recipients at relapse.

Liz Diana Cooke1, Robin Gemmill, Marcia Lee Grant.   

Abstract

Relapse after hematopoietic stem cell transplantation (HSCT) is a stressful event for patients and families, but provides an opportunity for education and psychosocial support. Little available research satisfies the needs of transplantation recipients at this critical time in the cancer trajectory. This article will apply the End-of-Life Nursing Education Consortium content principles to tailor an education session in an advanced practice nursing research intervention after a relapse from HSCT. The components were a specific session devoted to relapse, family-focused education and assessment, and bereavement follow-up. The details of the three steps are discussed with application to four case studies, which describe the variety of scenarios that can occur and illustrate how a standard approach should be tailored for each situation. In addition, the actual teaching tools and forms used for the intervention are included.

Entities:  

Mesh:

Year:  2011        PMID: 21810574      PMCID: PMC3246399          DOI: 10.1188/11.CJON.411-417

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  12 in total

1.  Traumatic grief as a risk factor for mental and physical morbidity.

Authors:  H G Prigerson; A J Bierhals; S V Kasl; C F Reynolds; M K Shear; N Day; L C Beery; J T Newsom; S Jacobs
Journal:  Am J Psychiatry       Date:  1997-05       Impact factor: 18.112

2.  Caregiver grief in end-stage dementia:using the Marwit and Meuser Caregiver Grief Inventory for assessment and intervention in social work practice.

Authors:  Sara Sanders; Samuel J Marwit; Thomas M Meuser; Paul Harrington
Journal:  Soc Work Health Care       Date:  2007

3.  Assessing pre-death grief in cancer caregivers using the Marwit-Meuser Caregiver Grief Inventory (MM-CGI).

Authors:  Samuel J Marwit; John T Chibnall; Rebecca Dougherty; Chrystal Jenkins; Jenifer Shawgo
Journal:  Psychooncology       Date:  2008-03       Impact factor: 3.894

4.  Evaluation of end-of-life nursing education for continuing education and clinical staff development educators.

Authors:  Pam Malloy; Betty R Ferrell; Rose Virani; Gwen Uman; Anne M Rhome; Barbara Whitlatch; Geraldine Bednash
Journal:  J Nurses Staff Dev       Date:  2006 Jan-Feb

5.  Approaching death: improving care at the end of life--a report of the Institute of Medicine.

Authors: 
Journal:  Health Serv Res       Date:  1998-04       Impact factor: 3.402

6.  Cancer and the family: an integrative model.

Authors:  John S Rolland
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

7.  A communication strategy and brochure for relatives of patients dying in the ICU.

Authors:  Alexandre Lautrette; Michael Darmon; Bruno Megarbane; Luc Marie Joly; Sylvie Chevret; Christophe Adrie; Didier Barnoud; Gérard Bleichner; Cédric Bruel; Gérald Choukroun; J Randall Curtis; Fabienne Fieux; Richard Galliot; Maité Garrouste-Orgeas; Hugues Georges; Dany Goldgran-Toledano; Mercé Jourdain; Georges Loubert; Jean Reignier; Fayçal Saidi; Bertrand Souweine; François Vincent; Nancy Kentish Barnes; Frédéric Pochard; Benoit Schlemmer; Elie Azoulay
Journal:  N Engl J Med       Date:  2007-02-01       Impact factor: 91.245

8.  Complicated bereavement: a national survey of potential risk factors.

Authors:  Julia Ellifritt; Kristine A Nelson; Declan Walsh
Journal:  Am J Hosp Palliat Care       Date:  2003 Mar-Apr       Impact factor: 2.500

9.  Family caregiver engagement in a coping and communication support intervention tailored to advanced cancer patients and families.

Authors:  Karen F Bowman; Julia H Rose; Rosanne M Radziewicz; Elizabeth E O'Toole; Rose A Berila
Journal:  Cancer Nurs       Date:  2009 Jan-Feb       Impact factor: 2.592

Review 10.  Relapse after allogeneic hematopoietic cell therapy.

Authors:  Marcel R M van den Brink; David L Porter; Sergio Giralt; Sydney X Lu; Robert R Jenq; Alan Hanash; Michael R Bishop
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-24       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.